Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | OPK | ADPT |
|---|---|---|
| Price | $1.39 | $26.28 |
| Change today | ▼ 4.79% | ▼ 2.30% |
| Market cap | $1.04B | $4.19B |
| Return, 3 months | 0.0% | +20.6% |
| Return, year to date | +10.3% | +61.8% |
| Return, 1 year | -10.3% | +69.0% |
| P/E (TTM) | -19.9 | -65.7 |
| P/B | 0.9 | 29.4 |
| P/E percentile vs own 5y | 14th | 2nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +4.3% | +21.5% |
| Net profit growth (YoY) | +94.3% | -56.1% |
| Gross margin | 40.8% | 75.6% |
| Operating margin | -28.6% | -12.2% |
| Net margin | -12.4% | -20.7% |
| Return on equity | -5.9% | -39.6% |
| Analyst target vs. price | +115.8% | +16.4% |
| Analyst buy share | 67% | 100% |
| RSI (14) | 33 | 46 |
| 30-day volatility | 54.1% | 55.4% |
| Max drawdown, 1 year | -30.4% | -39.3% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
